Clinical Investigation

Kidney International (1993) 44, 1109–1115; doi:10.1038/ki.1993.356

Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failure

Teresa Sagalés1, Victor Gimeno1, M Jesus Planella1, Nuria Raguer1 and Jorge Bartolome1

1Servei de Neurofisiologia Clínica and Servei de Nefrologia, Hospital General Universitari Vall d'Hebron, Barcelona, Spain

Correspondence: Dr Teresa Sagalés, Servei de Neurofisiologia Clínica, Hospital General Universitari Vall d'Hebron, 08035 Barcelona, Spain.

Received 27 January 1993; Revised 9 June 1993; Accepted 10 June 1993.

Top

Abstract

Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failure. Quantitative electroencephalography is a powerful tool to evaluate brain function, and preliminary data have shown its usefulness in the evaluation of patients with chronic renal failure (CRF). In this study, baseline values of different quantitative EEG variables, as well as data from the P300 component of the visual event-related potential, in 43 patients with chronic renal failure, were compared with those of a group of healthy subjects and with the results obtained after 3, 6, 9 and 12 months of treatment of these patients with rHuEPO. Baseline total power was much lower in patients with CRF than in healthy subjects, and the distribution of power among the frequency bands was also abnormal. rHuEPO promptly normalized total power and progressively improved power distribution, although full normality was not achieved. Mean dominant frequencies in brain areas were abnormal in patients with CRF, and progressive improvement was seen along the study. The latency of P300, which was increased before treatment, decreased in all subjects, but normal values were not reached. The same applies to the hypomanic and psychopathic scores of psychological tests. Altogether, brain dysfunction of CRF seems to substantially improve by treatment of the anemia with rHuEPO.

Top

References

  1. Eschbach JW, Adamson JW: Recombinant human erythropoietin: Implications for nephrology. Am J Kidney Dis 1:203–209, 1988
  2. Radtke HW, Claussner A, Erbes PM, Scheuerman EH, Schoeppe W, Koch KM: Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory renal function. Blood 54:877–884, 1979 | PubMed | ISI | ChemPort |
  3. Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM: Effect of human erythropoietin derived from recombinant DNA on the anemia of patients mantained by chronic hemodialysis. Lancet 2:1175–1177, 1986 | Article | PubMed | ISI | ChemPort |
  4. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial. N Engl J Med 316:73–78, 1987 | PubMed | ISI | ChemPort |
  5. Souheaver GT, Ryan JJ, De Wolfe AS: Neuropsychological patterns in uremia. J Clin Psychol 38:490–496, 1982
  6. Wolcott DL, Wellisch DK, Marsh JT, Schaeffer J, Landsverk J, Nissenson AR: Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients. Am J Kidney Dis 12:275–284, 1988 | PubMed | ChemPort |
  7. Teschan PE, Bourne JR, Reed RB, Ward JW: Electrophysiological and neurobehavioral responses to therapy: The National Cooperative Dialysis Study. Kidney Int 23 (Suppl 15):S58–S65, 1983
  8. Lewis EG, Dustman RE, Beck EC: Visual and somatosensory evoked potential characteristics of patients undergoing hemodialysis and kidney trasplantation. Electroencephal Clin Neurophysiol 44:223–231, 1978
  9. Marsh JT, Brown WS, Wolcott D, Landswerk J, Nissenson AR: Electrophysiological indices of CNS function in hemodialysis and CAPD. Kidney Int 30:957–963, 1986 | PubMed | ChemPort |
  10. Teschan PE, Ginn HE, Bourne JR: Quantitative indices of clinical uremia. Kidney Int 15:676–697, 1979
  11. Osberg JW, Meares GJ, Mckee DC, Burnett GB: Intellectual functioning in renal failure and chronic dialysis. J Chron Dis 35:445–457, 1982
  12. Hart RP, Pederson JA, Czerwinski AW, Adams RL: Chronic renal failure, dialysis and neuropsychological function. J Clin Neuropsychol 5:302–312, 1983
  13. Grimm G, Stockenhuber F, Schneeweiss B, Madl C, Zeitlhofer J, Schneider B: Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int 38:480–486, 1990 | Article | PubMed | ISI | ChemPort |
  14. Brown WS, Marsh JT, Wolcott D, Takushi R, Carr CR, Higa J, Nissenson AR: Cognitive function, mood and P3 latency: Effects of the amelioration of anemia in dialysis patients. Neuropsychologia 29:34–45, 1991
  15. Marsh JT, Brown WS, Wolcott D, Carr CR, Harper R, Schweitzer SV, Nissenson AR: rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 39:155–163, 1991 | PubMed | ISI | ChemPort |
  16. Culebras A, Kline MD, Ross GS, Hodge CH, Cruz A: Quantitative EEG mapping of cerebral ischemia. Neurology 36(Suppl 1):321, 1986
  17. Sagales T, Gimeno V, Calzada MD, Casellas F, Macia D, Soriano MV: Brain mapping analysis in patients with hepatic encephalopathy. Brain Topography 2:221–228, 1990
  18. Mody CK, McIntyre HB, Miller BL, Altman K, Read S: Computerized EEG frequency analysis and topographic brain mapping in Alzheimer's disease, in: Windows of the Brain, edited by Zappulla RA, LeFever FF, Jaeger J, Bilder R, New York, The New York Academy of Sciences, 1991, pp. 45–56
  19. Bourne JR, Teschan PE: Computer methods, uremic encephalopathy, and adequacy of dialysis. Kidney Int 24:496–506, 1983
  20. Balzar E, Saletu B, Khoss A, Wagner U: Quantitative EEG: Investigation in children with end-stage renal disease before and after haemodialysis. Clin Electroencephal 4:195–201, 1986
  21. Jonkman J, de Weerd AW, Poortvliet DCJ, Veldhuizen RJ, Duijn H, Rozeman CAM, Laman M: Neurometries in cerebral ischemia and uremic encephalopathy. Brain Topography 4:275–284, 1992
  22. Arieff AI: Neurological manifestations of uremia, in The Kidney, edited by Brenner BM, Rector FC, Philadelphia, WB Saunders, 1986, pp. 1731–1756
  23. Bendat JS, Piersol AG: Random Data: Analysis and Measurements Procedures, New York, John Wiley and Sons, 1971
  24. Nuwer MR: Quantitative EEG: Techniques and problems of frequency analysis and topographic mapping. J Clin Neurophysiol 5:1–43, 1988
  25. Morrison DF: Multivariate Statistical Methods, New York, McGraw-Hill Book Co., 1976
  26. Druml W, Roth E, Lenz K, Lochs H, Kopsa H: Phenylalanine and tyrosine metabolism in renal failure. Kidney Int 36(Suppl 27):S282–S286, 1989
  27. Biasioli S, Andrea GD, Feriani M, Chiaramonte S, Fabris A, Ronco C, La Greca G: Uremic encephalopathy: An updating. Clin Nephrol 25:57–63, 1986

Extra navigation

.
ADVERTISEMENT